ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 778 filers reported holding ASTRAZENECA PLC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,390 | -2.6% | 212,491 | +2.9% | 0.05% | +3.8% |
| Q2 2023 | $14,776 | +15.8% | 206,452 | +9.7% | 0.05% | +4.0% |
| Q4 2022 | $12,756 | -99.9% | 188,139 | +0.7% | 0.05% | +13.6% |
| Q3 2022 | $10,243,000 | +7.9% | 186,790 | -1.6% | 0.04% | -4.3% |
| Q4 2020 | $9,490,000 | -12.7% | 189,837 | -4.3% | 0.05% | -25.8% |
| Q3 2020 | $10,872,000 | +54.4% | 198,387 | +49.0% | 0.06% | +40.9% |
| Q2 2020 | $7,041,000 | +13.6% | 133,126 | -4.1% | 0.04% | -10.2% |
| Q1 2020 | $6,200,000 | +3.5% | 138,818 | +15.6% | 0.05% | +25.6% |
| Q4 2019 | $5,988,000 | +11.8% | 120,101 | -0.1% | 0.04% | 0.0% |
| Q3 2019 | $5,358,000 | +7.4% | 120,206 | -0.6% | 0.04% | +2.6% |
| Q2 2019 | $4,990,000 | +7.8% | 120,892 | +5.5% | 0.04% | 0.0% |
| Q1 2019 | $4,631,000 | +2.7% | 114,542 | -3.6% | 0.04% | -11.6% |
| Q4 2018 | $4,511,000 | -6.1% | 118,785 | -2.1% | 0.04% | +4.9% |
| Q3 2018 | $4,802,000 | -60.9% | 121,362 | -65.3% | 0.04% | -65.3% |
| Q2 2018 | $12,295,000 | -0.4% | 350,180 | -0.8% | 0.12% | -4.8% |
| Q1 2018 | $12,339,000 | +3.6% | 352,847 | +2.8% | 0.12% | 0.0% |
| Q4 2017 | $11,911,000 | +14.9% | 343,245 | +12.1% | 0.12% | +5.1% |
| Q3 2017 | $10,369,000 | +6.7% | 306,060 | +7.4% | 0.12% | -2.5% |
| Q2 2017 | $9,717,000 | +10.7% | 285,038 | +1.2% | 0.12% | +3.4% |
| Q1 2017 | $8,774,000 | +35.1% | 281,750 | +18.5% | 0.12% | +19.4% |
| Q4 2016 | $6,495,000 | -28.7% | 237,729 | -14.3% | 0.10% | -39.1% |
| Q3 2016 | $9,115,000 | +216.4% | 277,404 | +171.1% | 0.16% | +114.7% |
| Q1 2016 | $2,881,000 | +31.5% | 102,324 | +58.5% | 0.08% | +31.6% |
| Q4 2015 | $2,191,000 | -99.9% | 64,547 | +51.6% | 0.06% | -5.0% |
| Q4 2014 | $2,997,292,000 | -12.0% | 42,587 | -10.7% | 0.06% | -15.5% |
| Q3 2014 | $3,405,834,000 | -1.1% | 47,674 | +2.9% | 0.07% | -5.3% |
| Q2 2014 | $3,442,443,000 | -20.9% | 46,325 | -30.9% | 0.08% | -28.6% |
| Q1 2014 | $4,349,409,000 | +53.9% | 67,038 | +23.2% | 0.10% | +23.5% |
| Q3 2013 | $2,826,609,000 | +191.0% | 54,431 | +165.1% | 0.08% | -16.7% |
| Q2 2013 | $971,306,000 | – | 20,535 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |